Journal of Clinical Oncology, Vol 23, No 21 (July 20), 2005: pp. 4735-4741
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.02.899
Pediatric Melanoma: Risk Factor and Survival Analysis of the Surveillance, Epidemiology and End Results Database
John J. Strouse,
Thomas R. Fears,
Margaret A. Tucker,
Alan S. Wayne
From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore; Biostatistics Branch and Genetics Epidemiology Branch/Division of Cancer Epidemiology and Genetics and Pediatric Oncology Branch/Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Address reprint requests to John J. Strouse, MD, Division of Pediatric Hematology, 720 Rutland Ave, Ross 1125, Baltimore, MD 21205; e-mail: jstrous1{at}jhmi.edu
PURPOSE: To evaluate risk factors for the development of and factors influencing survival in pediatric melanoma.
PATIENTS AND METHODS: We evaluated 1,255 children (age < 20 years) and 2,673 young adults (age 20 to 24 years) with melanoma in the 2001 National Cancer Institute (NCI) Surveillance, Epidemiology and End Results (SEER) database. We estimated exposure to UV radiation based on Environmental Protection Agency (EPA) measurements.
RESULTS: The incidence of pediatric melanoma increased 46% (95% CI, 40 to 52) per year of age and 2.9% (95% CI, 2.1 to 3.6) per year from 1973 to 2001. Incidence rates were lower in black patients (95%; 95% CI, 98 to 90) compared with white patients and in male patients (39%; 95% CI 46 to 31) compared with females. Increased ambient UV radiation was associated with elevated risk (19% per kJ; 95% CI, 9 to 30). Children with melanoma had a 5-year melanoma-specific survival of 93.6% (95% CI, 91.9 to 94.9), which improved from 1973 to 2001. The hazard ratio of death from melanoma increased with male sex; older age; advanced disease; location of the primary other than extremities or torso; earlier year of diagnosis; and previous cancer.
CONCLUSION: The incidence of melanoma in the United States is increasing rapidly in children. Risk factors for pediatric melanoma include being white, being female, increasing age, and environmental UV radiation. Survival is decreased for children and adolescents with unfavorable prognostic factors (male sex, unfavorable site, and/or second primary or regional or distant metastasis). More effective therapeutic strategies are needed for these groups.
Supported by a National Cancer Institute K12 Training Grant, 2K12CA001709-11 (J.J.S.).
Presented at the 40th Annual Meeting of American Society of Clinical Oncology, New Orleans, LA, June 5-8, 2004.
Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. S. Driscoll and J. M. Grant-Kels
Estrogen Receptor Expression in Cutaneous Melanoma
Arch Dermatol,
January 1, 2009;
145(1):
73 - 75.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Oliveria, J. M. Satagopan, A. C. Geller, S. W. Dusza, M. A. Weinstock, M. Berwick, M. Bishop, M. K. Heneghan, and A. C. Halpern
Study of Nevi in Children (SONIC): Baseline Findings and Predictors of Nevus Count
Am. J. Epidemiol.,
January 1, 2009;
169(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Robinson, J. Kim, S. Rosenbaum, and S. Ortiz
Indoor Tanning Knowledge, Attitudes, and Behavior Among Young Adults From 1988-2007
Arch Dermatol,
April 1, 2008;
144(4):
484 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ma, F. Collado-Mesa, S. Hu, and R. S. Kirsner
Skin Cancer Awareness and Sun Protection Behaviors in White Hispanic and White Non-Hispanic High School Students in Miami, Florida
Arch Dermatol,
August 1, 2007;
143(8):
983 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Lange, B. E. Palis, D. C. Chang, S.-J. Soong, and C. M. Balch
Melanoma in Children and Teenagers: An Analysis of Patients From the National Cancer Data Base
J. Clin. Oncol.,
April 10, 2007;
25(11):
1363 - 1368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N. Markovic, L. A. Erickson, R. D. Rao, R. R. McWilliams, L. A. Kottschade, E. T. Creagan, R. H. Weenig, J. L. Hand, M. R. Pittelkow, B. A. Pockaj, et al.
Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis
Mayo Clin. Proc.,
March 1, 2007;
82(3):
364 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Cummins, J. M. Cummins, H. Pantle, M. A. Silverman, A. L. Leonard, and A. Chanmugam
Cutaneous Malignant Melanoma
Mayo Clin. Proc.,
April 1, 2006;
81(4):
500 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S A Oliveria, M Saraiya, A C Geller, M K Heneghan, and C Jorgensen
Sun exposure and risk of melanoma
Arch. Dis. Child.,
February 1, 2006;
91(2):
131 - 138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Herbst, D. F. Bajorin, H. Bleiberg, D. Blum, D. Hao, B. E. Johnson, R. F. Ozols, G. D. Demetri, P. A. Ganz, M. G. Kris, et al.
Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology
J. Clin. Oncol.,
January 1, 2006;
24(1):
190 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|